Search

everythinglearnresearchcommunity

for

Search:↓

The combined stem cell secretome in the skin care product effectively reduces inflammation and promotes tissue regeneration.

Noninvasive treatments like PRP and laser therapy can effectively promote hair growth and reduce hair loss.

Significant progress was made in understanding PXE, but effective treatments are still needed.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Effective delivery systems are crucial for siRNA hair loss treatments to work better.

Most trichological shampoo ingredients lack strong evidence for effectiveness against hair loss.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

CONSORT improves trial reporting but doesn't assess bias.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Public health decisions should rely on independent trials, not biased literature.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Hair follicle traits at 6 months can help select cashmere goats for breeding.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

The Trichoscan system was found to be inaccurate for measuring hair growth, needing better software to be useful.